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ABSTRACT A specific and sensitive procedure has been developed that reliably localizes
intracellular sites of free catalytic unit (C) dissociated from cAMP-dependent protein kinase .
The method is based on a FITC conjugate (F:PKI) of affinity column-purified heat-stable
protein inhibitor (PKI) of free C. The fidelity of this cytochemical probe was determined using
cultures of Reuber H-35 hepatoma cells that had been stimulated for 2 h with 0.1 mM DBcAMP,
or with diluent, then fixed with anhydrous acetone at -30°C . In these preparations the F:PKI
probe complexed with free C in cytoplasm, nucleolus, and, to a minor extent, in nucleoplasm .
Binding of the F:PKI molecule to free C was competitively diminished by arginine analogues,
guanidinium HCI and polyarginine, each used over a 2-log dose range . When the inhibitor's
arginine residues were blocked by reaction with cyclohexanedione it no longer inhibited
phosphotransferase activity of free C, and when fluorescinated it failed to localize C in
stimulated cells . Similarly, when F:PKI was preabsorbed with excess pure C it no longer
functioned as a cytochemical stain . Affinity column-purified antibody to free C also reduced
significantly the ability of F:PKI to complex with C in cell cultures stimulated with 0.1 mM
DBcAMP . 1 jug of antibody reduced by -10% the binding of F :PKI to all cell compartments
while 5 jug of antibody diminished binding by >50% . Together, these results indicate that the
F:PKI binds specifically, perhaps exclusively, to the catalytic units of cAMP-dependent protein
kinase . The cytochemical procedure, unlike its biochemical counterparts, is able to locate the
dissociation of cAMP-dependent protein kinase in individual cells of functionally or histolog-
ically complex cultures . Also, it reveals variations in the time- and dose-dependent activation
of the kinase amongst clonal cells stimulated with cyclic nucleotide analogues or hormones .
Numerous cellular responses are regulated by the binding of a
hormone or other agent to a cell surface receptor . This event
leads to the activation ofadenylate cyclase (1) and a consequent
increase in cyclic 3' :5' adenosine monophosphate (cAMP) . The
influence ofcAMP on subsequently activated processes appears
to be further mediated and amplified through the activation of
a cAMP-dependent protein kinase (1-6) . The holoenzyme form
of the kinase whether type I or type II consists of a dimeric
regulatory subunit (R) and two catalytic subunits (C) . The
binding ofcAMP to R causes the reversible dissociation of the
cAMP-independent C which is then able to catalyze the phos-
phorylation of a variety of protein substrates (2, 3, 7-9) .
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Although the dissociation of cAMP-dependent protein kinase
is thought to mediate a diversity of cellular functions, each of
these is initiated by a similar event, the generation of cAMP
(1-6) . How these responses are thereafter specifically brought
about is poorly understood but they may result from the
different affinities of the type I and type II isozymes for cAMP
(2, 3), from the ratio of isozymes (2, 3, 10), or from the temporal
and spatial kinetics of the kinase subunits relative to their
specific substrates (2, 9, 11, 12) . In this regard, little is known
about the subcellular distribution of R-cAMP and C during
the minutes and hours after their separation, i .e ., upon activa-
tion of the holoenzyme.
719Studies using differential centrifugation methods have fur-
nished tentative evidence that the holoenzymes dissociate in
cytoplasm where freed regulatory and catalytic units may
remain or can, with time, translocate to the nucleus (2, 11, 12) .
The presence offree C in the nucleus is though to be important
to the regulation of a variety of transcriptional events (2, 3, 9-
12) and may be relevant to cAMP-dependent protein kinase-
mediated control of cellular growth and differentiation (10) .
Immunocytochemical methods with heterospecific antisera
to the holoenzymes or their RI and RII subunits have con-
firmed the concept of nuclear translocation (13) . Unfortu-
nately, all of the available antibodies to the catalytic unit
crossreact extensively with both forms of the holoenzyme and
are thus unusable for locating only the free C (13) . This and
other problems inherent to indirect immunocytochemical pro-
cedures make them unsuitable for localizing C at unit cell
resolution . Even so, a morphological probe for the sites of
phosphotransferase activity is desirable, if not necessary, in
order to gain insight into how the CAMP-dependent kinases
though activated by a single event can engender a wide variety
of effects .
The fact that free C appears to be the effector component of
the holoenzyme suggested an alternative method for localizing
its subcellular distribution and movements, if any, with time
once dissociated from the intact isozymes . A number of labo-
ratories have reported the presence ofa heat-stable protein that
inhibits free C phosphotransferase activity (4) . This inhibitor
(PKI), found in a variety of tissues and characterized (14-20)
has a high affmity and specificity only for the free catalytic
unit of cAMP-dependent protein kinase (4, 14, 16) . It does not
bind to either form of the holoenzyme nor to the cyclic 3':5'
guanosine monophosphate(cGMP)-dependent protein kinase
(15, 16). It seemed reasonable therefore that the inhibitor
protein could be useful as probe for the direct cytochemical
localization of free C .
Here we describe the development ofa cytochemical method
employing a fluorescein isothiocyanate-conjugated inhibitor
(F:PKI) for the localization of the catalytic subunit and the
procedures used to assure its fidelity and sensitivity. Our com-
panion article which follows will describe the kinetics of free
C in a hormone-responsive tumor cell, as determined with the
localization procedure .
MATERIALS AND METHODS
To examine the effects of various stimulating agents on intact, living cells, we
used monolayer cultures of Reuber H-35 hepatoma kindly provided by Dr .
Wesley Wicks (University ofTennessee). Cells were seeded onto a sterile 12-mm
square glass cover slips in 10 x 50mm plastic petri dishes . The cells were grown
in Dulbecco's modified Eagle's medium (Gibco Laboratories, Grand Island
Biological Co., Grand Island, NY) containing 5% fetal calf + 5% calf serum
(Gibco Laboratories) .
Purification of Inhibitor
The protein inhibitor of adenosine 3':5'-monophosphate-dependent protein
kinase was purified to homogeneity from both rabbit skeletal muscle and bovine
brain according to Demaille et al. (16) with a protein kinase catalytic subunit
affinity column used to obtain homogeneous inhibitor (16, 17) . Using this
procedure essentially as described (16), we routinely obtained inhibitor which
was 400,000-500,000-fold pure and migratedas a single bandon 12.5% polyacryl-
amide gels . While the inhibitor protein is apparently quite stable during most of
the purification procedure with total yields approaching 30%, in solution it is
susceptible to denaturation in terms of its ability to inhibit the free catalytic
subunit . For this reason, the eluant from the phosphocellulose column (16), the
homogeneous inhibitor and the fluorescinated inhibitor were each stored at
-20°C as a lyophilized powder .
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Conjugation of Inhibitor Protein
with Fluorescein
Affinity chromatography-purified inhibitor (100 ltg) was dissolved in 2 ml of
50mM sodium carbonate, pH 8.5 .Twomg of fluorescein isothiocyanate (FITC)
bound to Celite (Sigma Chemical Co ., St. Louis, MO) was then added to the
inhibitor solution and allowed to react at room temperature for 2 min with
intermittent mixing. Afler this, the inhibitor was rapidly cooled to 2-4°C and
centrifuged at 20,000 g for 5min to remove the majority ofthe unreacted FITC .
The FITC-inhibitor conjugate (F:PKI) could then be separated from the remain-
der of the FITC by extensive dialysis in 10 mM Tris-HCl, pH 7.5, or by
chromatography on a Bio GelP4 column (0.5 x 5 cm) equipped with a Gilson
fluorescent column monitor . Each preparation ofF:PKI was then assayed for its
ability to inhibit the free catalytic subunit under standard assay conditions (see
below), placed in 100-Al aliquots, lyophilized, and stored dessicated at -20°C .
Assay for Inhibitor Activity
The protein kinase inhibitor was assayed according to a modification of the
method of DeLange et al. (21) . The assay mixture (0.10-0.15 ml) contained 0.01
Mpotassium phosphate buffer,pH 6.8,0.025 MMg acetate, t mM dithiothreitol,
100 ng mixed calf thymus histone, and -y-32PATP (1 mci/mmol) plus sufficient
unlabeled ATP for a fixed ATP concentration of 0.15 mM . Purified catalytic
subunit prepared according to Beavo et al. (22) as modified by Demaille et al.
(16) was preincubated for 5min at 30°C with varyingamountsofnative inhibitor
or its fluorescinated derivative . The reaction was initiated by the addition of the
ATPand allowed to proceed for 10 min at 30°C. The assay was terminated by
pipetting 0.06 ml of the reaction mixture onto Whatman 3M filters (2.3 cm)
which were then washed extensively in 10% trichloroacetic acid and95% ethanol,
dried, and counted in an omnifluor/toluene liquid scintillation cocktail.
Cyclohexanedione
Affinity column-purified inhibitor was reacted with cyclohexanedione as
described by Demaille et al. (16) . Briefly, this consisted oftreating inhibitor for
3 h with 150mM cyciohexanedione in 250mM sodium borate buffer at pH 9.0 .
Catalytic Subunit Antibody
Antibody to purified bovine heart catalytic subunit was generously provided
by Drs . Michael Murtaugh, Alton Steiner, and Peter Davies (University of
Texas). Free C was derivatized to keyhole limpet hemocyanin and injected into
recipient goats. The antibody obtained was prepared and characterized as de-
scribed elsewhere (23) . The heterospecific antiserum was purified by chromatog-
raphy on a catalytic subunit affinity column (16) andshippedto us packed in dry
ice . All of the affinity-purified antibody used in this study was from the same
bleed (Affi #3) .
Preparation of Cultures for Cytochemistry
During preliminary protocols a numberofagents (cyclicnucleotide analogues
orhormones) were incubated with H35 cells at various doses and periods oftime.
Using the kinase activation assay and cytochemical methods in parallel it was
found that 2-h exposure to 0.1 mm DBcAMP was optimal for dissociation ofthe
holoenzyme . These parameters were then held constant in order to establish the
remainder of the preparative methods . The time- and dose-related effectiveness
of other cyclic nucleotide analogues and of hormones is described in the accom-
panying article.
Cells grown on cover slips from control and DBcAMP-stimulated cultures
were washed for 3 min at 4°C with pH-7 .4 phosphate-buffered saline (PBS) .
Fixation was achieved by a variety ofmethods at either4°C or -30°C for 15-20
min. The criteria by which the various fixation procedures were compared were
that : (a) the intracellular free catalytic subunit could not be structurally altered
to the point of impairing its binding to theF:PKI probe ; (b) prefixation cellular
morphology should be conserved; and (c) fixation alone should not induce an
appreciable "background" fluorescence.
Paraformaldehyde (Polysciences Inc., Warrington, PA)was diluted with PBS
from a 10% stock solution in distilled waterand adjusted to pH 7.4 . Glutaralde-
hyde from a variety of sources was tried. The best results were obtained by
diluting freshly opened ampoules ofan 8% solution (Polysciences Inc.) with PBS,
then readjusting the pH to 7.4 . The dialdehyde mixture was made with equal
volumes of the 0.25% solutions of paraformaldehyde and glutaraldehyde. Di-
methylsuberimidate (DMS; Sigma Chemical Co .) was prepared and used as
described by Hand and Hassell (24) .
The paraformaldehyde-lysine-periodate (PLP) (25) fixative consisted of 50MM t.-lysine, 10mM sodium meta-periodate, and 0.25% paraformaldehyde in 50
mM PBS which was made isosmotic by the addition of sucrose. Methanol and
methanol: acetic acid (1 :3 vol/vol) were tried only twice, as they greatly disrupted
cellular morphology . Ethanol or acetone (Mallinckrodt Inc., Science Products
Div ., St . Louis, MO) were each made essentially anhydrous with 4A molecular
sieves (Linde PO Box 372, South Plainfield NJ)and used to treat the cells at 4°C
or -30°C . The4°C preparations were unsuitable and no results are presented
here . An attempt wasmade to quench the background fluorescence induced by
the fixatives containing aldehydes or DMS. t.-lysine monohydrochloride (Sigma
Chemical Co.) wasadded to PBS to achieve the desired concentration (20-100
mM) and stirred continuously until solubilized. Sodium borohydride (Sigma
Chemical Co .) solutions (10-100 mM) were similarly made and their pH was
adjusted to 8.2 at which point they most effectively react with free aldehyde
groups (26) . After fixation, cover slips were immersed in one of these reagents
and allowed to react at 4°C for 15 min. Triton X-100 (scintillation grade,
Research Products International Corp ., Mt. Prospect, IL) was diluted to 0.0125
or 0.10% with PBS. Filipin (Upjohn Co ., Kalamazoo, MI) was solubilized with
dimethylsulfoxide (DMSO) (Mallinckrodt Inc.) and brought to the final concen-
tration (10 or 100 lag/ml) with PBS (0.5% DMSO in working solution) . Fixed
cultures were exposed to either Triton or Filipin for 15 min at 4°C . Dimethyl-
sulfoxide(DMSO) was diluted with PBSandadjusted to pH 7.4. Prefixedcultures
were placed in DMSO for 15 min at 4°C .
After fixation or a postfixation treatment, cover slips were rinsed for 3 min in
PBS at 4°C, placed in a humidity chamber, and covered with 100 111 oftheF:PKI
diluted with PBS or with PBS alone . Cover slips were then incubated at 4°C for
3-96 h, rinsed with PBS, then either covered with glycerol:PBS or dehydrated
with anhydrous acetone at -30°C, and mounted on glass slides with Entellan
(EM Laboratories, Inc., Elmsford NY).
Fluorescence Microscopy
All microscopy was performed with an Olympus Vanox microscope equipped
with a 200-W HBO ultraviolet source, a BG excitation filter, and a 515-nm
barrier filter or with a Leitz Ortholux microscope fitted with a specificexcitation
barrier filter (k2:LEITZ), and varioorthomat camera . Kodak Tri-X film was
exposed atASA800and developed for 12 min with Kodak D-76. To display the
relative fluorescence intensity of each preparation, all images were exposed for
the same amount of time. This time was determined by making 10 exposures of
the most fluorescent preparation with the automatic photometer . The average o£
these times, which varied by <10%, was then used to photograph all other
preparations within the same experiment . For each experiment all rolls of film
were processed together and prints were made with the grade of paper and
exposure and development times held constant.
RESULTS
In order for theF:PKI to be a specific probe for localization of
the free catalytic subunit the inhibitor protein must retain its
high affinity for C following treatment with fluorescein isothi-
ocyanate . Fig . i shows the relative ability of equivalent con-
centrations of PKI and F:PKI to inhibit the activity of the free
catalytic subunit in vitro under standard assay conditions .
Comparison ofthe effects of PKI and F:PKI upon the activity
ofprotein kinase indicated that if an appropriate technique for
the fluorescination of PKI was employed (see Materials and
Methods) no loss in inhibitory activity could be observed. More
rigorous conditions for fluorescination (greater concentration
ofFITC and/or longer reaction times) did result in a significant
reduction in the ability of F:PKI to inhibitC (data not shown) .
A major difficulty in establishing any cytochemical or im-
munochemical procedure is the method of fixation chosen .
Early trials using unfixed or critical-point-dried cells were not
successful . Ofthe various fixation methods tried (see Materials
and Methods), anhydrous acetone at -30°C best satisfied all
of our requirements .
Specificity of Fluorescinated
Inhibitor Localization
Once the method of fixation was established it became
possible to test the specificity of the F:PKI interaction with free
C . The inhibitor protein binds via its arginine residues to the
substrate site of free C (3, 16) . Arginine analogues, therefore,
act as competitors toward PKI for the substrate site as judged
by biochemical assays (16) . To determine whether they do so
in acetone-preserved cells, cultures were stimulated for 2 h with
0 .1mMDBcAMP or with diluent only, then fixed and prepared
for cytochemistry as described above . Preparations were then
stained with 100 pl of the F:PKI diluted 1:20 (i.e. 1 .25 tag/ml)
with PBS alone or with PBS containing 10-200mM guanidin-
ium hydrochloride or 10-200 ;uM polyarginine .
Fig . 2 a depicts a culture stained with PBS diluted F:PKI .
About 75% of the cells exhibit intense fluorescence in cytoplasm
and nucleolus . Companion cultures that were incubated with
an identical amount of the probe containing in addition 100
mM guanidinium HCl (Fig . 2b) or 100 gM polyarginine (Fig.
2e) show significantly less fluorescence . Approximately the
same percentage of cells contain dissociated C in cytoplasm
and nucleolus but the amount of F:PKI bound is reduced
appreciably by each of the analogues.
When affinity column-purified inhibitor was treated with
cyclohexanedione its ability to inhibit the phosphotransferase
capacity ofC was virtually abolished, as reported by Demaille
et al. (16) . The reaction mixture alone, in the absence of
cyclohexanedione, reduced by -10% the inhibitor's biologic
activity, but this effect was insignificant compared to that
caused by the complete reaction mixture . When the chemically
altered inhibitor was fluorescinated it conjugated with an
equivalent amount of FITC as did the untreated PKI (deter-
mined with a fluorometer) . However, the cyclohexanedione-
modified F:PKI no longer functioned as a cytochemical probe
(Fig . 2d) . In fact, fluorescence ofthese preparations was nearly
equivalent to that of unstimulated-unstained cultures (blank
controls) .
If the F:PKI was binding only to the free catalytic unit it
was reasonable to expect that excess exogenousC could reduce
the amount ofthe probe available to complex with endogenous
C . Fluorescinated inhibitor (1 .25 hg/ml) was prereacted with
homogeneously pure bovine heart catalytic subunit (10 ttg/ml)
for 3 h at 4°C . 100-ttl aliquots ofthis material was then used to
stain fixed cultures that had been stimulated for 2 h with 0.1
mM DBcAMP . As shown in Fig . 2e, when preabsorbed with
C the F:PKI no longer is usable for the localization of endog-
enously dissociated catalytic unit.
To establish that the FITC-conjugated inhibitor interacts
with free C of acetone-fixed cells in a manner equivalent to
that of the unlabelled inhibitor, cultures were stained with
F:PKI andPKI mixed in varying molar ratios . Fig. 2f-h shows
the results of one of three such competitive inhibition experi-
ments . In all cases the H35 cells were stimulated for 2 h with
0 .1 mM DBcAMP .
When the PKI:F:PKI ratio is 10 :1 (Fig . 2f ), the fluorescence
intensity of cells declines markedly from that observed when
diluted F:PKI (1.25 tlg/ml) is used alone (Fig. 2a) . Fluores-
cence intensity is reduced further, to an unworkably low level,
at a 20 molar excess of PKI (Fig. 2g) and it is abolished at a
40-fold molar excess (Fig . 2h) . Although the amount of F:PKI
bound declines in proportion to the increasing amount of
unlabeled inhibitor protein, the subcellular distribution of the
probe is unaltered .
It appears from these results that the F:PKI probe and PKI
bind specifically to free C in acetone-fixed cells in a manner
which parallels their ability to inhibit catalytic subunit activity
measured biochemically. In an attempt to determine whether
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721or not the F:PKI bound to cellular proteins in addition to C,
the cytochemical procedure was performed in the presence of
antibody to catalytic subunit .
Cultures were stimulated for 2 h with 0 .1 mM DBcAMP,
then fixed and prepared for cytochemistry . Two procedures
were used to treat the fixed cells with F:PKI and antibody to
the catalytic subunit. In the first fixed cultures were preincu-
bated for 3 h at 4°C with 1 or 5 lAg of affinity chromatography
purified antibody to C or with 5 ILg of preimmune serum
protein. They were then stained with the probe at one of two
dilutions (1 .25 tLg/ml or 0.63 tLg/ml) in the continued presence
of antibody . Alternatively, cultures that had been similarly
stimulated with DBcAMP were stained with a mixed solution
containing 1 or 5 yg of antibody or 5 Itg of preimmune serum
and one of the two concentrations of the F:PKI probe . The
first procedure (preincubation) was expected to provide the
antibody ample opportunity to complex withC such that when
the F:PKI was added afterwards it would not be able to quickly
displace C . The coincubation preparations, where antibody
and F:PKI were added simultaneously, should, on the other
hand, furnish the antibody and the F:PKI equal access to
dissociated C . Figs . 3a-h shows the results of one of two such
studies . Unstimulated cultures stained with the high concentra-
tion ofF:PKI (1 .25 lAg/ml) in the presence of5 ttg ofpreimmune
serum exhibited the normal number (-5%) of H-35 cells with
spontaneously active cAMP-dependent protein kinase (Fig .
3 d) . In parallel, control cultures exposed to the F:PKI and 5
tLg of antibody, the endogenously dissociated free C was ren-
dered unavailable to the probe by 5 ,ug of the catalytic unit
antibody (Fig. 3 h) .
In cultures stimulated with DBcAMP the intensity of fluo-
rescence was essentially unaffected by 5 ttg of preimmune
serum (Fig. 3 a and e). In the presence of a constant amount of
preimmune serum the fluorescence intensity was, however,
directly dependent on the concentration of F :PKI used (com-
pare Fig . 3 a and e) . When stimulated, fixed cultures were
exposed to C antibody before being stained with F:PKI, the
amount of probe bound was significantly diminished in pro-
portion to the concentration ofantibody used. 1 ttg of antibody
(Fig. 3 6 and,f) reduced F:PKI binding relative to that oftheir
respective control cultures treated with preimmune serum (Fig.
2 a and e) . This decline in fluorescence was similar for both
concentrations ofF:PKI employed (in Fig . 3, compare b-a and
f-e) . When the amount of antibody was increased to 5 frg/
culture (Fig . 3 c and g) the quantity of F:PKI bound was
reduced to about one-half that of preimmune serum controls
in those cases where the high concentration (1 .25 ttg/ml) of
F:PKI was used (Fig. 3 c) . When a lesser amount of the F:PKI
(0.63 Ftg/ml) was employed the 5 ttg of antibody was even more
effective in its ability to prevent binding of the probe to free C
(Fig. 3 g) .- Irrespective of the amount of antibody or F:PKI
used, the fluorescence observed relative to the preimmune
serum controls was a reduction only in intensity, not in the
subcellular location of the residualF:PKI .
DISCUSSION
Our purpose was to develop a morphologic probe that could
be used for observing the subcellular location of cAMP-de-
pendent protein kinase after its dissociation . Others have found
that antisera to the free C subunit of the kinase extensively
crossreact with both forms of the holoenzyme (13, 28) . To
overcome this problem will most likely require generating a
monospecific antibody that recognizes determinants ofC that
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FIGURE 1 Figure depicts the relative abilities of affinity column-
purified inhibitor (PKI, ") and its fluorescinated derivative (F :PKI,
" ) to reduce the phosphotransferase activity of a constant amount
of free C.
are inacessible when it is associated with the regulatory subunit .
Alternatively, we have devised a direct cytochemical method
employing a fluorescinated conjugate of affinity column-puri-
fied heat-stable inhibitor protein . The inhibitor protein (PKI)
binds specifically to free C but not to either of the holoenzyme
forms or to the cyclic GMP-dependent kinase (2, 4, 15, 16, 29) .
The affinity of PKI forC (K; 2 x 10-9 M) is much greater than
that ofC for any ofits known substrates (K; for Histone 2b 3.2
x 10-5 M) (16). The high affinity of the inhibitor and its
relatively low molecular weight suggested that it would be an
excellentspecies for direct cytochemistry.
Of the fixation procedures tried, anhydrous acetone at
-30°C gave the best results . Although this mode of preserva-
tion slightly disrupted cellular morphology, the acetone ade-
quately stabilized substructure such that it did not deteriorate
appreciably during the 48-h incubation with the F:PKI . Also,
acetone did not impair the affinity of C for the F:PKI probe .
In this regard the catalytic subunit has been reported to retain
full activity in 1.33 M urea or 1 mM SDS (16) and has been
purified in active form from acetone powder of rat liver (30) .
Of the other fixatives tried, only paraformaldehyde at con-
centrations of 0.25% or less appears to be usable. However, at
those low concentrations cellular preservation was no better
than that achieved with -30°C acetone. Further, the aldehyde
induces a nonspecific fluorescence, mainly in cytoplasm, i .e .,
in the blue-green wavelength, which interferes with observing
the F:PKI (emisson 515 nm) . This hindrance renders all of the
aldehydes used in this study unsuitable fixatives for studying
the early stages (-I min) of kinase activation following stim-
ulation ofcultures with low doses of hormone or cyclic nucleo-
tide analogues (see accompanying manuscript) .
The times of incubation with the F:PKI (1 .25-0.63 ,ug/ml)
ranged from 3 to 96 h . At the earliest interval a low level of
specific subcellular fluorescence was observed . After 24 h of
staining at 4°C, the fluorescence intensity increased signif-
icantly although it was confined to the same cellular compart-
ments as before . Maximal binding of the F:PKI probe was
reached at 48 h of incubation, after which no increase occurred .
In all cases the subcellular distribution of the F:PKI-C com-
plexes was similar .
We found that by using higher concentrations of the F:PKIFIGURE 2
￿
Cultures of H-35 cells were stimulated with 0 .1 mM DBcAMP then stained with 100 fal of F:PKI in PBS alone (1.25 tLg/ml)
(A) or with F:PKI :PBS made 100 mM with guanidinium hydrochloride (B) or 100 fuM with polyarginine (C) . The preparation in D
was stained with inhibitor fluorescinated after reaction with cyclohexanedione . E displays a culture stained with F:PKI (1 .25 fag/ml)
preabsorbed with free catalytic unit (10 fag/ml) . F-H demonstrate the effect of competition between unlabeled inhibitor and FITC-
conjugated inhibitor for the free C of H35 cells stimulated for 2 h with 0 .1 mM DBcAMP . All preparations were stained with the
same amount of F:PKI (1 .25hg/ml) used routinely (A) but in the presence of a 10 ( F ), 20 ( G) or 40 (H) molar excess of unlabeled
inhibitor .
(6-12.5 wg/ml) it was possible to reduce the time of incubation
with the probe to 6-12 h at 4°C or 3 h at room temperature .
While this yielded a fluorescence intensity equivalent to that
of preparations stained for a longer time with a lesser amount
of FTKI, it occasionally caused an increase in background
fluorescence . Even though this could be eliminated by washing
FLETCHER AND
stained cultures with 250 mM KCl (16), it interfered with
observing the modest fluorescence in unstimulated-stained
(control) cultures (e.g., Fig. 2 D) . Although it is acceptable to
stain maximally stimulated preparations for short periods with
higher concentrations of FTKI, this procedure can mask the
minimal fluorescence (i.e ., minimal dissociation of cAMP-de-
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The influence of catalytic subunit antibody on the ability of F:PKI to complex with free C . Cultures A-C and E-G were
stimulated with DBcAMP . A-C were stained with 100 tLI of F:PKI (1.25 /Ag/ml) in the presence of: 5 Wg of preimmune serum (A) ; 1
FLg of antibody (B) ; 5 Ng of antibody (C) . E-G were stained with 100 jul of F:PKI (0.63 t`g/ml) and : 5 fig of preimmune serum (E) ; 1
f~g of antibody (F) ; 51Ág of antibody (G) . D and H are unstimulated cultures stained with F:PKI (1 .25 ttg/ml), with either 5 jug of
preimmune serum (D) or 5 Wg of antibody (H) .
724pendent protein kinase) of cultures stimulated for short times
or with low doses of nucleotide analogues or hormones . In the
interest of uniformity we find it best to use a 48-h incubation
at 40°C with no more than 1.25 FLg/ml concentration ofF:PKI .
Fluorescination did not alter the biologic activity of the
purified inhibitor based upon its ability to reduce the phospho-
transferase activity of free C (Fig. 1) . Clearly then, F:PKI must
bind to the substrate site ofC (2, 3, 16, 17), with an avidity like
that of the unconjugated inhibitor . It follows that F:PKI be-
haves similarly when employed as a cytochemical probe . To
date, however, we have not been able to establish a direct
procedure capable of determining whether the F:PKI binds in
vitro to molecules other than free C (e.g., to isolate the probe
bound to cellular supernatant proteins separated by PAGE) .
To do so would require the ability to monitor an extremely
minute amount of fluorescence, but at the moment this is
technologically not feasible . We are, however, unaware of any
published or unpublished evidence that the inhibitor binds to
cellular proteins other than the free C from cAMP-dependent
protein kinase (2-4, 15-20) . Even so, these limitations made it
necessary to establish that as a cytochemical probe the F:PKI
binds predominantly, perhaps exclusively, to the free catalytic
unit of cAMP-dependent protein kinase .
There is ample evidence that the arginyl residues of the
kinase inhibitor protein are necessary to its binding to free C
(3, 16) . Demaille et al . (16) described three classes of protein
kinase inhibitors, based on theirKi values, that are competitive
toward protein substrates. Using in vitro assays, guanidinium
hydrochloride and polyarginine were observed to be effective
in the millimolar and micromolar range, respectively, in com-
petition with the inhibitor protein for the substrate site ofC . In
the cytochemical procedure these arginine analogues were
similarly effective in reducing the binding of F:PKI to all
cellular constituents (Fig. 2B-C) . Because of the inhibitor's
high affinity for the substrate site (K; = 2 x 10-9M) it was not
possible, using competitive inhibitors, to completely abolish
the binding of F:PKI to cells that had been stimulated with
cyclic nucleotide analogues. However, when the inhibitor pro-
tein itself was modified by reaction with cyclohexanedione
such that it no longer diminished the phosphotransferase activ-
ity of free C, when fluorescinated it also did not stain cells in
which cAMP-dependent protein kinase was maximally acti-
vated (Fig. 2 D) . In a reciprocal study it was found that
preabsorption ofF:PKI with excess C caused a marked reduc-
tion in its binding to stimulated cells (Fig. 2E) . In fact, the
negligible fluorescence of these preparations was equivalent to
that of preparations incubated with cyclohexanedione-reacted
F:PKI (compare Fig. 2Dand E) . These findings in conjunction
with the fact that native PKI effectively competed with F:PKI
for dissociated C (Fig. 2F-H) indicate that the fluorescinated
inhibitor specifically occupies the substrate site of the free
catalytic units. We interpret this to validate the concept that
the F:PKI interacts with free C in acetone-fixed cells in a
manner similar, if not identical to, its interaction with C as
determined biochemically . The fact that this interaction is not
only specific for C but may be confined to the dissociated
kinase is further supported by the results using antibody to
purified catalytic unit . The catalytic subunit affinity column-
purified antibody significantly inhibited the binding ofF:PKI
to H-35 cells. As was the case for competition of the F:PKI
with arginine analogues (Figs . 2B and C) or competitive
inhibition with unfluorescinated PKI (Fig . 2F-H), only the
amount of probe bound was diminished, not its subcellular
distribution . Due to the scarcity of antibody we were unable to
use a quantity capable ofcompletely abolishing F:PKI binding
to stimulated cells, although in unstimulated preparations 5
Fig of antibody did eliminate F:PKI binding to endogenously
dissociated free C (Fig . 3H) . In another study using porcine
ovarian granulosa cells, 5 itg of the affinity column-purified
antibody to free C reduced by 90% the amount ofF:PKI bound
to cells that had been stimulated for 30 min with 0.1 mM
8BrcAMP (manuscript by these authors in preparation) .
It appears then that the F:PKI probe binds predominantly
to C and not to a host of other cellular proteins in addition.
Even though the antibody crossreacts with the cAMP-depend-
ent protein kinase holoenzyme (M . Murtaugh, A . Steiner, and
P . Davies, personal communication), this would not be re-
flected in a diminution of F:PKI binding as inhibitor does not
complex with the kinase holoenzyme (2-4, 16) . If the F:PKI
were able to bind holoenzyme in addition to free C, then there
would be no increase in cellular fluorescence in short-term
(e.g., 30 min) stimulated preparations relative to unstimulated
controls. Clearly, the stimulation does lead to an increased
fluorescence .
The large amount of affinity-purified antibody needed to
cause a 50% decline in F:PKI binding implies that only a
fraction of the antiserum protein is directed toward determi-
nants ofC that are used by the fluorescinated inhibitor . While
we do not know what the determinants are, the substrate
binding site is at least partially involved in that 1 ttg of affinity
column-purified antibody was required to reduce by 50% the
phosphotransferase activity of 10 ng of catalytic subunit (Mur-
taugh, Steiner, and Davies, personal communication) . This
indicates that the antibody has a K i for C in the micromolar
range and may explain its inability to eliminate fully the
binding ofF:PKI which has an affinity for free C three orders
of magnitude greater (reference 16 and Fig . 1) .
From the accumulation of results obtained it can be con-
cluded that the F:PKI conjugate binds specifically to the
substrate site of free catalytic subunit dissociated from cAMP-
dependent protein kinase . This specificity along with the high
affinity for C renders the F:PKI valuable for localizing at unit
cell resolution the distribution of C in cells stimulated by a
variety of agents . While it is certain that the probe binds
specifically to C, it remains unclear that it binds exclusively to
the active kinase . If the F:PKI binds to proteins other than C
they must be in minute quantities or possess a number of
characteristics which are identical to those of the catalytic
subunit . On the basis of the data described above, this pro-
tein(s) would have to possess the following characteristics: (a)
it must exhibit the ability to bind F:PKI in a time- and dose-
related fashion which is proportional to the activation of
cAMP-dependent protein kinase ; (b) it must require for bind-
ing the presence of specific active arginine residues in the
F:PKI in a manner indistinguishable from the free catalytic
subunit; and (c) it must have the capacity to cross-react with
affinity column-purified antibody directed against the free
catalytic subunit . To our knowledge no known protein other
than the free catalytic subunit exhibits all of these properties .
Perhaps as important as the specificity and sensitivity of the
F:PKI probe is its adaptability . To date we have used the
procedure to follow the temporal and spatial kinetics of free C
in ovarian granulosa cells (31), cells from anterior pituitary
(32), and in normal and neoplastic adrenocortical cells (33) . In
addition to its use on culture preparations, we have recently
adapted the procedure for application on cryotome sections of
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725intact tissues . The tissue method has been used to study the
kinetics of cAMP-dependent protein kinase activation in liver
(34), anterior pituitary (32), ovary (31), and adrenalgland (33) .
Unlike biochemical methods such as kinase activation as-
says, the cytochemical procedure is capable of discerning the
activation of cAMP-dependent protein kinase in single cell
types of a histologically or functionally complex culture or
tissue . For example, cultured cells from the anterior pituitary
that respond to luteinizinghormone releasing hormone can be
distinguished from neighbor cells that do not respond (32) .
Also, populations of granulosa cells in ovarian follicles that
preferentially dissociate kinase in response to follicle-stimulat-
ing hormone can be differentiated from granulosa cells re-
sponding only to luteinizinghormone (31) . In view of this and
its established validity we anticipate that the procedure for
localizing subcellular sites of free C will be useful in a variety
of systems .
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